SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wharf Rat who wrote (1244299)7/3/2020 10:14:46 PM
From: Sdgla2 Recommendations

Recommended By
locogringo
Mick Mørmøny

  Read Replies (1) of 1576669
 
More WINING Michigan Hydroxychloroquine Study Shows Significant Benefit for Treatment – Media Shocked…
Posted on July 3, 2020 by sundance
A Henry Ford Health Clinic study shows significant decreases in the death rate among patients to used Hydroxychloroquine as a treatment. Many U.S. media outlets are ignoring the result; however, even CNN has admitted the “surprise” study findings.



MICHIGAN – A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.

Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.

Continue reading ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News